| Patients with 6-week imaging |
184 |
89.8 |
|
| Tumors with 6-week imaging |
278 |
|
81.8 |
| Incomplete ablation |
10 |
5.0 |
2.9 |
| Median imaging follow-up (range) (months) |
10.9 (0.0–80.0) |
|
|
| Patients with imaging follow-up |
210 |
95.9 |
|
| Tumors with imaging follow-up |
327 |
|
96.2 |
| Local recurrence |
29 |
13.9 |
8.5 |
| Median time to LR (range) (months) |
9.9 (0.5–33.4) |
|
|
| Regional recurrence |
73 |
34.8 |
21.4 |
| Median time to RR (range) (months) |
9.5 (0.7–33.2) |
|
|
| Metastatic recurrence |
16 |
8.1 |
4.7 |
| Median time to MR (range) (months) |
11.8 (2.2–73.4) |
|
|
| Median survival (range) (months) |
14.8 (0.1–80.0) |
|
|
